Navigation Links
Quincy Bioscience Promotes Older Driver Safety Awareness Week
Date:12/4/2013

hes everyone safe traveling this holiday season and encourages a proactive approach for safe driving. Learn more at http://www.prevagen.com.

About Quincy Bioscience:
Quincy Bioscience is a biotechnology company based in Madison, Wis. that focuses on the discovery, development and commercialization of novel technologies to support good health in aging. The company’s products focus on supporting memory and cognitive health. Quincy Bioscience is set apart by its cutting-edge applications of the protein apoaequorin, which is breaking new ground in the area of brain health.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Read the full story at http://www.prweb.com/releases/2013/12/prweb11388878.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Quincy Bioscience Launches Complimentary Online Memory Games
2. Quincy Bioscience Launches New Version of “The Brain Health Guide”
3. Quincy Bioscience Makes Inc. 500
4. 5000 List of America’s Fastest Growing Companies
5. NewWave Biosciences Chooses Aero Fulfillment for e-Commerce Distribution of New Product to Reduce Inflammation
6. Market Publishers Ltd and Select Biosciences Sign Partnership Agreement
7. Centrillion Biosciences Launches Cloud and Mobile-based Sequencing Application
8. Dunn Foundation awards bioscience grants
9. RANK protein promotes the initiation, progression and metastasis of human breast cancer
10. Scientists discover mechanism that promotes lung cancer growth and survival
11. Alcoholics Anonymous participation promotes long-term recovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... ... ... Food Bank will hopefully be getting a large donation of canned food items at ... SC are making it their mission to collect as many canned items as possible. Donations ... the public as well. As part of the canned food drive, these local chiropractors will ...
(Date:7/3/2015)... , ... July 03, 2015 , ... Scientists at several ... to mesothelioma with even minimal asbestos exposure. Click here to read the complete ... University of Hawaii Cancer Center, Cedars Sinai Medical Center, and New York University exposed ...
(Date:7/3/2015)... Buffalo, NY (PRWEB) , ... July 03, 2015 ... ... Noonday Learning Lecture took place on June 25, 2015 at 1:00pm. The Association ... presentation explored issues pertaining to injured bicyclists and practical points of investigating these ...
(Date:7/3/2015)... ... 2015 , ... First Choice Emergency Room , the largest network of ... the new Medical Director of its Frisco facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:7/3/2015)... ... , ... The Celebrity Dresses is currently running a promotion through July 30th. ... have the opportunity to get 10% discount on orders that are over $100. , ... to use coupon codes or remember redemption codes. , There is a low ...
Breaking Medicine News(10 mins):Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2
... body to the ageing process and may increase the ... and diabetes, researchers have found. ,These days, the average ... more developed countries has decreased from nine hours to ... increased demands of work and more leisure activities. ...
... or very long menstrual cycles have a higher risk ... panic because the risk can be reduced markedly by ... // ,Menstrual cycles 40 days or longer ... sort of underlying metabolic abnormality. "Over an eight-year follow-up, ...
... Sciences Inc. said it has received approval from the ... antiretroviral agent Viread (tenofovir disoproxil fumarate) for the treatment ... ,Like Viread, such drugs work by blocking the process ... is the first nucleotide analogue reverse transcriptase inhibitor to ...
... are at high risk of suffering a stroke, say US ... used by opticians and GPs to mass-screen patients.Strokes are caused ... vessels. , ,Drugs that are effective at ... keen to identify people with changes to their network of ...
... angiotensin-converting enzyme (ACE) inhibitor ramipril, used for the treatment ... ventricular hypertrophy (LVH), thereby lowering the risk of stroke ... from the landmark Heat Outcome Prevention Evaluation (HOPE) study ... LVH in a broad range of patients – those ...
... India has finally decided to get its act together on ... get a large number of laboratories activated on testing them, ... plants to ensure the raw material itself meets standards. The ... a series of measures to boost the medicinal plants sector. ...
Cached Medicine News:Health News:Deprived sleep leads to ageing 2Health News:New light on Cardiology 2
(Date:7/3/2015)... July 3, 2015 According ... & Cardiac Rhythm Management Market ECG, Implantable Loop ... Implantable Cardioverter Defibrillator, Dual Chamber Pacemaker, CRT-D, CRT-P ... the global Cardiac Monitoring (CM) and Cardiac Rhythm ... $26,646.5 Million by 2020 from $21,137.7 Million in ...
(Date:7/3/2015)... STOCKHOLM , July 3, 2015 ... agreement with Broda Technologies Co., Ltd., operating in both ... use the company,s proprietary IntelliGel ® supramolecular hydrogel ... under development and other ophthalmic therapies. The Broda technology ... polymer solution is a free-forming liquid and with low ...
(Date:7/2/2015)... 2015 ResMed Inc. (NYSE: RMD ) today ... year ended June 30, 2015 results on Thursday, July 30, ... press release with ResMed,s results will be issued after 1:00 ... webcast to discuss operating results and future outlook. ... US Pacific Time and the live webcast of the call ...
Breaking Medicine Technology:Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results 2
... Poster Presentation at EASL on April 13, 2007, ... 13,/PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. and LG Life,Sciences, ... showing that,ANA380 (LB80380) retains potency against multiple mutant ... to lamivudine,adefovir, entecavir or telbivudine, during a poster ...
... GUARDIA (COMO), Italy--(BUSINESS WIRE)--Apr 13, 2007 -,Gentium, S.p.A. ... product, Defibrotide, will be the subject,of two poster ... Annual Meeting being held at the Los Angeles,Conference ... On Monday, April 16, 2007, from 1:00 p.m. ...
Cached Medicine Technology:ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 2ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 3ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 4ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 5ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 6Gentium's Defibrotide Highlighted in Two Poster Presentations at,American Association for Cancer Research Annual Meeting 2Gentium's Defibrotide Highlighted in Two Poster Presentations at,American Association for Cancer Research Annual Meeting 3Gentium's Defibrotide Highlighted in Two Poster Presentations at,American Association for Cancer Research Annual Meeting 4
Straight, with guard. Ideal for multi-directional manipulation....
... are individually adjusted for perfect focus where ... on paper. This, along with Keeler's wide ... that whatever the patient's pupil size, you ... of view. Lithium-ion technology provides a longer ...
... Beta 200 ophthalmoscope, ... glare-free direct ophthalmoscope. Heine's ... patent #4,963,014) along with ... construction, make the Beta ...
... optics. The separation of illumination and observation ... system avoids corneal and iris reflex (Gullstrand-principle). ... the whole of the illuminated section of ... Conventional ophthalmoscopes often let you see only ...
Medicine Products: